MAPS donated $15,046.25 to McLean Hospital, affiliated with Harvard Medical School. The donation is to enable Dr. John Halpern to develop a protocol for the use of MDMA-assisted psychotherapy in the treatment of anxiety and depression in end-stage cancer patients, and for work related to obtaining approval for the study from the McLean Institutional Review Board (IRB) and the FDA. The donation will support a portion of Dr. Halpern’s time from now until the end of December 2003.
If this project is approved, it will represent the first psychedelic research at Harvard since 1965 and will signal the beginning of the post-Leary era.